Meta-Analysis the Effect of Oral and Injection Contraceptives on Breast Cancer


  • Dilma’aarij Dilma’aarij Masters Program in Public Health,Universitas Sebelas Maret
  • Setyo Sri Rahardjo Faculty of Medicine,Universitas Sebelas Maret
  • Eti Poncorini Pamungkasari Faculty of Medicine,Universitas Sebelas Maret


Background: Oral contraceptives and injec


Alsolami FJ, Azzeh FS, Ghafouri KJ, Ghaith MM, Almaimani RA, Almasmoum HA, Abdulal RH,et al. (2019). Determinants of breast cancer in Saudi women from Makkah region: A case-control study (breast cancer risk factors among Saudi women). BMC Public Health, 19(1): 1

Amadou A, Fabre A, Torres MG, Ortega OC, AngelesLA, McKenzie F, BiessyC, et al. (2013). Hormonal therapy and risk of breast cancer in Mexican women. PLoS ONE, 8(11).

Ayu G, Dewi T, Hendrati LY, Ua FK (2015). Analisis risiko kanker payudara berdasar riwayat pemakaian kontrasepsi hormonal dan usia (Analysis of breast cancer risk based on history of hormonal contraceptive use and ag ). Periodic Epidemiol J. 3(1): 12

Bardaweel SK, Akour AA, Al-Muhaissen S, Alsalamat HA, Ammar K (2019). Oral contraceptive and breast cancer: Do benefits outweigh the risks? A case-control study from Jordan. BMC Women

Busund M, Bugge NS, Braaten T, Waaseth M, RylanderC, Lund E (2018). Progestin-only and combined oral contraceptives and receptordefined premenopausal breast cancer risk: The Norwegian Women and cancer study. Int J Cancer.142(11): 2293

CEBMa (2014). Critical Appraisal for cross-sectional study. Amsterdam.

Globocan (2020). Indonesia - Global cancer observatory. WHO; Int Agency for Res on Cancer, 2018. Available at:

Heikkinen S, Koskenvuo M, Malila N, Sarkeala T, Pukkala E, Pitkaniemi J. (2016). Use of exogenous hormones and the risk of breast cancer: results from self-reported survey data with validity assessment. Cancer Causes and Control, 27(2): 249

Kemenkes (2015). Panduan Penatalaksanaan Kanker Payudara (Breast Cancer Management Guide). Kementerian Kesehatan Republik Indonesia. 1

Kemenkes RI (2019). Profil Kesehatan Indoneisa 2019, Kementerian Kesehatan Republik Indonesia.

Kemenkes RI (2019) Profil Kesehatan Indonesia 2018 [Indonesia Health Profile 2018]. Available at:

Kementerian Kesehatan RI Badan Penelitian dan Pengembangan (2018). Hasil Utama Riset Kesehatan Dasar, Kementrian Kesehatan Republik Indonesia. Available at:

Li CI, Beaber EF, Tzue M, Tang C, Porter PL, Daling JR, Malone KE (2012). Effect of depomedroxyprogesterone acetate on breast cancer risk among women 20 to 44 years of age. Blood Cancer Discov, 72(6). 2028

Moradinazar M, Marzbani B, Shahebrahimi K, Shahabadi S, Marzbani B, Mora-dinazar Z (2019). Hormone therapy and factors affecting fertility of women under 50-year-old with breast cancer. Breast Cancer: Targets and Therapy, 11: 309

Morch LS, Skovlund CW, Hannaford PC, Iversen L, Fielding S, Lidegaard O (2018). Contemporary hormonal contraception and the risk of breast cancer. New Eng J Med. 377(23): 2228

Murti B (2018). Prinsip dan metode riset epidemiologi (Principles and methods of epidemiological research). 5th Edition. Surakarta: Program Studi Ilmu Kesehatan Masyarakat.

Patel K, Moi U, Torrorey R, Rono S, Eldoret U, Lugaria L, Busakhala N (2015). Risk factors associated with aggressive breast cancer forms seen in young women of Western Kenya. J Med Sci Clin Res. 3(5): 5857-5867.

Shapiro S, Rosenberg L, Hoffman M, Truter H, Cooper D, Rao S, Dent D, et al. (2021). Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. Am J of Epidemiol, 151(4):396

Urban M, Banks E, Egger S, Canfell K, Connell D, Beral V,Sitas F (2012). Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black South African women: Case-control study. PLoS Med, 9(3): 1

Yulianti I (2016). Faktor-faktor risiko kanker payudara. J Public Health, 4. Available at:




How to Cite

Dilma’aarij, D., Rahardjo, S. S., & Pamungkasari, E. P. (2021). Meta-Analysis the Effect of Oral and Injection Contraceptives on Breast Cancer. Journal of Maternal and Child Health, 6(2), 238–249. Retrieved from